B-cell Acute Lymphoblastic Leukemia
📧 Sign up to get email alerts when something new happens for B-cell Acute Lymphoblastic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-08-08Clinical Trial Update: A Study of HY004 Treatment in Adult Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r B-ALL) [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating HY004 for adult relapsed/refractory B-cell Acute Lymphoblastic Leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-19Clinical Trial Update: Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL [Phase 1, Phase 2]
The Phase 1/2 trial evaluating CAR19 regulatory T cells (CAR19-tTreg) for relapsed/refractory CD19+ B-cell acute lymphoblastic leukemia has …
-
CLINICAL_TRIALS withdrawal · 2024-07-12Clinical Trial Update: Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell Therapy [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating Interferon-Beta-1a (FP-1201) to prevent toxicities after CD19-directed CAR T-cell therapy has been withdr…
-
CLINICAL_TRIALS withdrawal · 2017-04-10Clinical Trial Update: A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
A clinical trial evaluating JCAR015 in adults with B-cell acute lymphoblastic leukemia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-14Clinical Trial Update: Study of Efficacy and Safety of CTL019 in Adult ALL Patients [Phase 2]
A Phase 2 study examining CTL019 (tisagenlecleucel) in adults with B-cell acute lymphoblastic leukemia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2017-01-27Clinical Trial Update: Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 dose-escalation study in relapsed or refractory acute myeloid leukemia and relapsed/refractory B-cell acute lymphoblastic leukemia…
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Testing a Reduced Conditioning Regimen FB2A2 Preceded by a Fractionated Radio-immunotherapy (RIT) With 90Y-Epratuzumab Before Allogeneic Stem Cell Transplantation for Patients With Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
This clinical trial update reports withdrawal of a Phase 1/2 study evaluating a reduced conditioning regimen with 90Y-epratuzumab radioimmun…
-
CLINICAL_TRIALS withdrawal · 2017-01-19Clinical Trial Update: Study Evaluating the Efficacy of 90Yttrium-epratuzumab in Adults With CD22+ Relapsed/Refractory B-ALL [Phase 2]
A Phase 2 study evaluating 90Yttrium-epratuzumab for CD22-positive relapsed/refractory B-cell acute lymphoblastic leukemia in adults has bee…
-
CLINICAL_TRIALS withdrawal · 2015-10-30Clinical Trial Update: Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Phase 2]
A Phase 2 study evaluating Nilotinib with combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic …